Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(n/a)
# 4,885
Out of 5,182 analysts
25
Total ratings
9.09%
Success rate
-29.27%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Overweight | $270 → $255 | $178.98 | +42.47% | 2 | Apr 23, 2026 | |
| MMED MiniMed Group | Initiates: Overweight | $19 | $12.94 | +46.83% | 1 | Mar 31, 2026 | |
| A Agilent Technologies | Maintains: Overweight | $180 → $160 | $114.87 | +39.29% | 2 | Mar 3, 2026 | |
| WAT Waters | Maintains: Equal-Weight | $423 → $350 | $300.73 | +16.38% | 2 | Feb 23, 2026 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,550 → $1,475 | $1,262.48 | +16.83% | 2 | Feb 10, 2026 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $292.13 | -2.44% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $55.11 | +135.89% | 7 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $325.99 | -18.40% | 8 | Jul 31, 2025 |
Danaher
Apr 23, 2026
Maintains: Overweight
Price Target: $270 → $255
Current: $178.98
Upside: +42.47%
MiniMed Group
Mar 31, 2026
Initiates: Overweight
Price Target: $19
Current: $12.94
Upside: +46.83%
Agilent Technologies
Mar 3, 2026
Maintains: Overweight
Price Target: $180 → $160
Current: $114.87
Upside: +39.29%
Waters
Feb 23, 2026
Maintains: Equal-Weight
Price Target: $423 → $350
Current: $300.73
Upside: +16.38%
Mettler-Toledo International
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $1,550 → $1,475
Current: $1,262.48
Upside: +16.83%
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $292.13
Upside: -2.44%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $55.11
Upside: +135.89%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $325.99
Upside: -18.40%